KM110329 in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, multicentre trial – study protocol

BACKGROUND: Atopic dermatitis is a chronic inflammatory skin disease with a high prevalence rate and a large socioeconomic cost. There are many treatments for atopic dermatitis, such as antihistamine, tacrolimus and corticosteroids. However, due to concern about the adverse effects, many patients se...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Complement Altern Med
Päätekijät: Cheon, Chunhoo, Park, Sunju, Park, Jeong-Su, Oh, So-Mi, Jang, Soobin, Go, Ho-Yeon, Jang, Bo-Hyoung, Shin, Yong-Cheol, Ko, Seong-Gyu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222770/
https://ncbi.nlm.nih.gov/pubmed/24279519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6882-13-335
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia